Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-006978
Filing Date
2021-03-29
Accepted
2021-03-29 06:30:49
Documents
65
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 587018
2 ex31-1.htm EX-31.1 17224
3 ex31-2.htm EX-31.2 17307
4 ex32-1.htm EX-32.1 5869
  Complete submission text file 0001493152-21-006978.txt   4305739

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE brtx-20200331.xml EX-101.INS 765072
6 XBRL SCHEMA FILE brtx-20200331.xsd EX-101.SCH 50584
7 XBRL CALCULATION FILE brtx-20200331_cal.xml EX-101.CAL 53577
8 XBRL DEFINITION FILE brtx-20200331_def.xml EX-101.DEF 221531
9 XBRL LABEL FILE brtx-20200331_lab.xml EX-101.LAB 383959
10 XBRL PRESENTATION FILE brtx-20200331_pre.xml EX-101.PRE 316102
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 21779401
SIC: 8090 Services-Misc Health & Allied Services, NEC